Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2026 (Letter of Intent)
Funding Amounts: $750,000 total ($250,000/year for 3 years, including up to 10% indirect costs)
Summary: Supports innovative, high-risk research to advance understanding and treatment of neurodegenerative diseases through interdisciplinary collaboration.
Key Information: Forecasted cycle—dates are projected; U.S. academic institutions only; only one LOI per PI per cycle.